COPDchronic obstructive pulmonary diseasetype 2 inflammationdupilumabNOTUStriple therapyBOREAS
…and Week 52 improvement in SGRQ (r=–0.2201; P<0.0001), and E-RS:COPD total scores (r=–0.1543; P<0.0001); the placebo arm did not sho…
4articles mentioning diseases
10disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: Type 2 inflammation ×
Type 2 inflammation
This disease is selected. Its supporting articles are shown below.
Articles mentioning Type 2 inflammation
4 articles · page 1 of 1COPDchronic obstructive pulmonary diseaseType 2 inflammationDupilumab
…o-controlled trials, enrolled 1,874 patients (40–85 years) with COPD, moderate-to-severe airflow limitation, and type 2 inflammation…
chronic obstructive pulmonary diseaseCOPDtype 2 inflammationdupilumabtriple inhalation therapyBOREASNCT03930732
… exacerbation rates and improved lung function in patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation. This post hoc analysis explored…
chronic obstructive pulmonary diseaseCOPDtype 2 inflammationdupilumabBOREAStriple therapyNOTUS
…rticosteroids (SCS) and antibiotics are often co-prescribed for chronic obstructive pulmonary disease (COPD) exacerbations. However, prolonged use can be associated …